Video | 15 May 2024 Webinar: Part 2 - Access to GLP-1s (medicines like Ozempic) and SGLT-2s for people living with type 2 diabetes 1 min DIABETES The MSF Access Campaign hosted a webinar on why we need newer medicines to treat people living with type 2 diabetes in low- and middle-income countries, and why people’s access to GLP-1s (eg, Ozempic) may be a major challenge. Read, watch, share Filter by - Any -BlogFeature storyIssue briefLetterPress releaseResearch articleStatementTechnical briefVideo Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines Letter | 23 September 2024 Diabetes Open letter to Novo Nordisk on barriers to accessing diabetes medicines Video Video | 14 May 2024 Diabetes Webinar: Part 1 - Lowering the price of insulin everywhere: let’s make it a reality 1 min Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min Issue brief | 08 May 2024 Diabetes Defeating the Double Standard in Diabetes Care Photo credit: Carmen Yahchouchi/MSF Press release Press release | 27 March 2024 Diabetes New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens 6 min Load More
Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min
Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Novo Nordisk on barriers to accessing diabetes medicines
Video Video | 14 May 2024 Diabetes Webinar: Part 1 - Lowering the price of insulin everywhere: let’s make it a reality 1 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 27 March 2024 Diabetes New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens 6 min
